VolitionRX Stock Price, News & Analysis (NYSEAMERICAN:VNRX)

$3.14 -0.11 (-3.38 %)
(As of 02/22/2018 03:52 AM ET)
Previous Close$3.25
Today's Range$3.11 - $3.30
52-Week Range$2.08 - $4.71
Volume33,235 shs
Average Volume115,175 shs
Market Capitalization$79.03 million
P/E Ratio-6.25
Dividend YieldN/A
Beta-0.97

About VolitionRX (NYSEAMERICAN:VNRX)

VolitionRX logoVolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

Receive VNRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic & Testing Substances
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:VNRX
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-6.25
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.52)
Net IncomeN/A
Net MarginsN/A
Return on Equity-104.17%
Return on Assets-79.40%

Miscellaneous

EmployeesN/A
Outstanding Shares26,520,000

VolitionRX (NYSEAMERICAN:VNRX) Frequently Asked Questions

What is VolitionRX's stock symbol?

VolitionRX trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "VNRX."

How were VolitionRX's earnings last quarter?

VolitionRX Ltd (NYSEAMERICAN:VNRX) issued its quarterly earnings data on Thursday, May, 11th. The medical research company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.01. View VolitionRX's Earnings History.

When will VolitionRX make its next earnings announcement?

VolitionRX is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for VolitionRX.

Where is VolitionRX's stock going? Where will VolitionRX's stock price be in 2018?

1 analysts have issued 1-year price targets for VolitionRX's shares. Their forecasts range from $10.00 to $10.00. On average, they expect VolitionRX's share price to reach $10.00 in the next year. View Analyst Ratings for VolitionRX.

Who are some of VolitionRX's key competitors?

Who are VolitionRX's key executives?

VolitionRX's management team includes the folowing people:

  • Martin Charles Faulkes, Executive Chairman of the Board (Age 73)
  • Cameron John Reynolds, President, Chief Executive Officer, Director (Age 46)
  • David Vanston, Chief Financial Officer, Treasurer (Age 49)
  • Jacob Vincent Micallef, Chief Scientific Officer (Age 61)
  • Jason Bradley Terrell, Chief Medical Officer and Head of US Operations (Age 37)
  • Rodney Gerard Rootsaert, Secretary (Age 46)
  • Alan Colman, Director (Age 68)
  • Edward W. Futcher Ph.D., Independent Director (Age 54)
  • Guy Archibald Innes, Independent Director (Age 61)
  • Habib Skaff, Independent Director (Age 37)

How do I buy VolitionRX stock?

Shares of VolitionRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is VolitionRX's stock price today?

One share of VolitionRX stock can currently be purchased for approximately $3.14.

How big of a company is VolitionRX?

VolitionRX has a market capitalization of $79.03 million.


MarketBeat Community Rating for VolitionRX (VNRX)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about VolitionRX and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

VolitionRX (NYSEAMERICAN:VNRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$10.00$10.00$10.00
Price Target Upside: 232.23% upside175.48% upside175.48% upside249.65% upside

VolitionRX (NYSEAMERICAN:VNRX) Consensus Price Target History

Price Target History for VolitionRX (NYSEAMERICAN:VNRX)

VolitionRX (NYSEAMERICAN:VNRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/6/2018HC WainwrightSet Price TargetBuy$10.00View Rating Details
9/7/2016Rodman & RenshawLower Price TargetBuy$12.00 -> $10.00View Rating Details
(Data available from 2/22/2016 forward)

Earnings

VolitionRX (NYSEAMERICAN:VNRX) Earnings History and Estimates Chart

Earnings by Quarter for VolitionRX (NYSEAMERICAN:VNRX)

VolitionRX (NYSEAMERICAN VNRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018($0.16)N/AView Earnings Details
11/9/2017Q3 2017($0.14)($0.15)ViewN/AView Earnings Details
8/9/2017Q2 2017($0.14)($0.13)ViewN/AView Earnings Details
5/11/20173/31/2017($0.14)($0.13)ViewN/AView Earnings Details
3/10/2017Q4 2016($0.14)($0.12)ViewN/AView Earnings Details
11/10/2016Q3 2016($0.14)($0.15)ViewN/AView Earnings Details
8/11/2016Q216($0.12)($0.13)ViewListenView Earnings Details
5/13/2016Q116($0.13)($0.13)ViewN/AView Earnings Details
3/11/2016Q4 2015($0.15)($0.15)ViewN/AView Earnings Details
11/4/2015Q315($0.13)($0.16)$0.20 millionViewN/AView Earnings Details
8/11/2015Q215($0.14)($0.10)$0.11 millionViewN/AView Earnings Details
5/12/2015Q115($0.14)($0.12)ViewN/AView Earnings Details
3/18/2015Q4 2014($0.12)ViewN/AView Earnings Details
11/6/2014($0.09)($0.13)$0.13 million$0.02 millionViewN/AView Earnings Details
8/1/2014Q2 2014($0.07)ViewN/AView Earnings Details
5/27/2014($0.10)($0.09)ViewN/AView Earnings Details
5/15/2014Q1 2014($0.10)($0.09)ViewN/AView Earnings Details
3/28/2014Q4 2013($0.10)($0.07)ViewN/AView Earnings Details
10/31/2013Q3 2013($0.10)($0.08)ViewN/AView Earnings Details
7/29/2013Q2 2013($0.10)($0.10)ViewN/AView Earnings Details
5/6/2013Q1 2013($0.10)($0.09)ViewN/AView Earnings Details
3/29/2013Q4 2012($0.10)($0.16)ViewN/AView Earnings Details
11/14/2012Q3 2012($0.10)($0.09)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.10)($0.10)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.10)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

VolitionRX (NYSEAMERICAN:VNRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for VolitionRX (NYSEAMERICAN:VNRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

VolitionRX (NYSEAMERICAN VNRX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for VolitionRX (NYSEAMERICAN:VNRX)
Institutional Ownership by Quarter for VolitionRX (NYSEAMERICAN:VNRX)

VolitionRX (NYSEAMERICAN VNRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2017David Cecil VanstonInsiderBuy2,750$2.84$7,810.002,750View SEC Filing  
8/16/2017Cameron John ReynoldsInsiderBuy3,630$2.77$10,055.101,114,673View SEC Filing  
10/5/2016David Matthew KratochvilCFOBuy10,000$5.00$50,000.0010,000View SEC Filing  
5/20/2016Cameron John ReynoldsCEOSell3,390$3.54$12,000.601,125,016View SEC Filing  
5/15/2015Cameron John ReynoldsCEOBuy1,500$3.33$4,995.00View SEC Filing  
2/11/2015Guy Archibald InnesDirectorBuy50,000$3.75$187,500.00View SEC Filing  
9/15/2014Martin Charles FaulkesDirectorBuy5,000$2.16$10,800.00View SEC Filing  
9/3/2014Rodney Gerard RootsaertInsiderSell28,000$1.80$50,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

VolitionRX (NYSEAMERICAN VNRX) News Headlines

Source:

SEC Filings

VolitionRX (NYSEAMERICAN:VNRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

VolitionRX (NYSEAMERICAN VNRX) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.